Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
37.1 HKD | +4.21% | +2.49% | -24.44% |
04-30 | Keymed Biosciences' Allergy Treatment NDA Accepted by NMPA | MT |
04-29 | Keymed Biosciences Allergy Drug Achieves Phase III Clinical Trial End Points | MT |
- Stock Market
- Equities
- 2162 Stock
- News Keymed Biosciences Inc.